CORC

在结果中检索

CORC

浏览/检索结果: 共260条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Shielding engineering progress for the QTT buildings 会议论文
Toulouse, France, September 23, 2019 - September 26, 2019
作者:  Liu, Qi;  Liu, Ye;  Chen, Mao-Zheng;  Su, Xiao-Ming;  Liu, Feng
收藏  |  浏览/下载：37/0  |  提交时间：2021/04/13
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
Subcarrier Allocation of Cognitive OFDM Systems with SWIPT-Enabled Relay 会议论文
International Conference on Communications, Signal Processing, and Systems, CSPS 2018, Dalian, China, 2018-07-14
作者:  Lin, Yuanrong;  Lu, Weidang;  Ye, Qibin;  Peng, Hong;  Zhan, Yu
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：35/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
Backstepping controller for trajectory tracking of wheeled mobile robot based on particle swarm optimization 会议论文
作者:  Dai, Yongwen;  Jia, DIng;  Guo, Lun;  Ye, Shengwang;  Luo, Dan
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
The age variation of HER2 immunohistochemistry positive rate in gastric cancer 会议论文
作者:  Qin, Yejun;  Liu, Jianping;  Li, Daiqiang;  Wang, Guoping;  Nie, Xiu
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace